UCLB Investor Breakfasts 2008
NOVEMBER Breakfast: The UCL Biomedical Translational Research Pipeline - A Snapshot
Date: November 25th
Venue: The Haldane Room, Wilkins Building, University College London
An exciting look at UCL biomedical research
Thank you to those who attended the November Investor Breakfast. For those who were unable to attend, we're sorry not to have seen you, but please click on the link below to download the presentations that you missed.
- Prof. Mike Wilson - UCL Eastman Dental Institute: Development of novel anti-microbial surface coatings.
- Prof. Benny Chain - UCL Dept of Immunology: Delopment of a Novel HIV Vaccine.
- Dr Adrian Hobbs and Prof. David Selwood - UCL Dept of Pharmacology and the Wolfson Institute of Biomedical Research: Development of Agonsists at Natriuretic Peptide Receptor C.
- Prof. Robert Speller - UCL Dept of Medical Phys and Bioengineering: Development of a coded Aperture-based X-Ray Phase Contrast Imager.
- Prof. Philip Hawkins - UCL Centre for amyloidosis and Acute Phase Proteind, Royal Free and University College Medical School: Development of C-Reactive Protein Depleting Agents for the Treatment of Myocardial Infarction and Stroke.
- Prof. Peng Khaw, UCL Institute of Opthamology: Novel Tissue Implantable slow release tablet therapy to prevent scarring
- Dr Jude Oben - UCL Centre for Hepatology: The use of the Alpha 1 Receptor Antagonist Prazosin for the Treatment of Non-Alcoholic Fatty Liver Disease.
- Dr Daffyd Thomas -Director D-Gen: Development of Diagnostics and Therapies for Prion Related Diseases.
If you have any queries on projects or companies presented, please do not hesitate to get in touch. We hope to see you at our next Investor Breakfast at 8am on 30th September where we will present on consultancy opportunities with UCL.
Return to Investor Breakfasts main page
